US Patent Issued to North Carolina State University on May 13 for "Chromosomal assessment to diagnose urogenital malignancy in dogs" (North Carolina Inventor)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,504, issued on May 13, was assigned to North Carolina State University (Raleigh, N.C.).

"Chromosomal assessment to diagnose urogenital malignancy in dogs" was invented by Matthew Breen (Apex, N.C.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This invention is directed to a method of diagnosing bladder cancer in dogs."

The patent was filed on Oct. 21, 2019, under Application No. 16/659,095.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12297504&OS=12297504&RS=12297504

Disclaime...